Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthase

Bibliography

• WALSH TJ: Invasive fungal infections: problems and challenges for developing new antifungal compounds. In: Emerging Targets in Antibacterial and Antifungal Chemotherapy Sutcliffe JA, Georgopapadakou NH (Eds.), Chapman and Hall, New York, USA (1992):349–373.
   Google Scholar
• BECK-SAGUE C, JARVIS W: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect. Dis. (1993) 1 67:1247–1251.
   Google Scholar
• GEORGOPAPADAKOU NH, WALSH TJ: Human mycoses: drugs and targets for emerging pathogens. Science (1994) 2 6 4:371–373.
   Google Scholar
• GEORGOPAPADAKOU NH, WALSH TJ: Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob. Agents Chemother. (19 9 6) 40:279–291.
   Google Scholar
• GEORGOPAPADAKOU NH: Antifungals: mechanism of action and resistance, established and novel drugs. Curr. Opin. Microbic)]. (1998) 1:547–557.
   PubMed Web of Science ®Google Scholar
• •A useful review that focuses on agents under development and on emerging targets.
   Google Scholar
• GEORGOPAPADAKOU NH: Antifungals targeted to the cell wall. In: Emerging Drugs: the Prospect for Improved Medicines. Bowman WC, Fitzgerald JD, Tylor JB (Eds.), Ashley Publications Ltd., London, UK (1996):261–276.
   Google Scholar
• SHEEHAN DJ, HITCHCOCK CA, SIBLEY CM: Current and emerging azole antifungal agents. Clin. Mkrobiol. Rev. (1999) 12:40–79.
   PubMed Web of Science ®Google Scholar
• SANGLARD D, ISCHER F, CLABRESE D, DE MICHELI M, BILLE J: Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. Drug Resist. Updates (1998) 1:255–265.
   PubMed Web of Science ®Google Scholar
• •A thorough review of the azole resistance mechanisms in clinical isolates focusing on Candida.
   Google Scholar
• WHITE TC, MARR KA, BOWDEN RA: Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clin. Mkrobiol. Rev. (1998) 11:382–402.
   PubMed Web of Science ®Google Scholar
• CURRENT WL, TANG J, BOYLAN C et al.: Glucan biosyn-thesis as a target for antifungals: the echinocandin class of antifungal agents. In: Antifungal Agents: Discover)/ and Mode of Action. Dixon GK, Copping LG, Hollomon DW (Eds.), Bios Scientific Publishers, Oxford, UK (1995):143–160.
   Google Scholar
• KURTZ MB, DOUGLAS CM: Iipopeptide inhibitors offungal glucan synthase. J. Med. Vet. Mycol. (1997) 35:79–86.
   PubMedGoogle Scholar
• DICKSON RC: Sphingolipid functions in Saccharomyces cerevisiae: comparison to mammals. Ann. Rev. Biochem. (1998) 67:27–48.
   PubMed Web of Science ®Google Scholar
• •Discusses the most recent developments in yeast sphingolipids focusing on S. cerevisiae.
   Google Scholar
• LESTER R, DICKSON R: Sphingolipids with inositolphosphate-containing head groups. Adv. Lipid Res. (1993) 26:253–274.
   PubMedGoogle Scholar
• DICKSON RC, LESTER RL: Yeast sphingolipids. Biochim. Biophys. Acta (1999) 1 42 6:347–357.
   Google Scholar
• SKRZYPEK M, LESTER R, DICKSON R: Suppressor gene analysis reveals an essential role for sphingolipids in transport of glycosylphosphatidylinositol-anchored proteins in Saccharomyces cerevisiae. J. Bacteriol (1997) 179:1513–1520.
   PubMed Web of Science ®Google Scholar
• TOLEDO MS, LEVERY SB, STRAUS AH et al.: Characteriza-tion of sphingolipids from mycopathogens: specific factors correlating with expression of 2-hydroxy fatty acyl (p-Delta 3-un satur ation in cerebrosides of Para coccidioides brasiliensis and Aspergillus fumigatus. Biochemistry (1999) 38:7294–7306.
   PubMed Web of Science ®Google Scholar
• ZHONG W, JEFFRIES MW, GEORGOPAPADAKOU NH: Inhibition of inositol phosphorylceramide synthase by aureobasidin Ain Candida and Aspergillusspecies. Antimicrob. Agents Chemother. (2000) 44:651–653.
   PubMed Web of Science ®Google Scholar
• MERRILL AH, SWEELEY CC: Sphingolipids: metabolism and cell signaling. In: Biochemistry of Lipids, Lipoproteins and Membranes. Vance D, Vance JE (Eds.), Elsevier Science, New York, USA (1996):309–339.
   Google Scholar
• BROWN DA, LONDON E: Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol. Chem. (2000) 275:17221–17224.
   PubMed Web of Science ®Google Scholar
• HUWILER A, KOLTER T, PFEILSCHIFTER J, SANDHOFF K: Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta (2000) 1485:63–99.
   PubMed Web of Science ®Google Scholar
• HANNUN YA, OBEID LM, DBAIBO GS: Ceramide: a novel second messenger and lipid mediator. In: Lipid Second Messengers. Handbook of Lipid Research, Vol. 8. Bell SM, Exton H, Prescott SM (Eds.), Plenum Press, New York, USA and London, UK (1996):177–204.
   Google Scholar
• HANNUN YA, LUBERTO C: Ceramide in the eukaryotic stress response. Trends Cell Biol. (2000) 10:73–80.
   PubMed Web of Science ®Google Scholar
• IKAI K, TAKESAKO K, SHIOMI K et al.: Structure of aureobasidin A. J Antibiot. (1991) 44:925–933.
   PubMed Web of Science ®Google Scholar
• NAGIEC M, NAGIEC E, BALTISBERGER J et al.: Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylcera-mide synthase defect in a mutant of Saccharomyces cerevisiae by the AURI gene. J. Biol. Chem. (1997) 272:9809–9817.
   Google Scholar
• ••A seminal paper that revealed the biochemical function ofthe target of aureobasidin, clearing the way for SAR studies with inhibitors. It is perhaps instructive to note that the gene for the enzyme, discovered in 1994, offered no clues as to its biochemical function.
   Google Scholar
• ENDO M, TAKESAKO K, KATO I, YAMAGUCHI H: Fungicidal action of aureobasidin A, a cyclic depsip ep-tide antifungal antibiotic, against Saccharomyces cerevisiae. Antimicrob. Agents Chem other. (1997) 41 (3):672–676.
   PubMed Web of Science ®Google Scholar
• BUEDE R, RINKER-SCHAFFER C, PINTO W, LESTER R,DICKSON R: Cloning and characterization of LCBI, a Saccharomyces gene required for biosynthesis of the long-chain base component of sphingolipids. [published erratum appears in J. Bacteriol (1993) 175:919] Bacteriol (1991) 173:4325–4332.
   Google Scholar
• NAGIEC M, BALTISBERGER J, WELLS G et al: The LCB2 gene of Saccharomyces and the related LCBI gene encode subunits of serine palmitoyltransferase, the initial enzyme in sphingolipid synthesis. Proc. Natl. Acad. ScL USA (1994) 91:7899–7902.
   PubMed Web of Science ®Google Scholar
• ZHAO C, BEELER T, DUNN T: Suppressers of the Ca2±-sensitive yeast mutant (csg2) identify genes involved in sphingolipid biosynthesis. Cloning and characterization of SCS/, a gene required for serine palmitoyltransferase activity. J. Biol. Chem. (1994) 269:21480–21488.
   Google Scholar
• GABLE K, SLIFE H, BACIKOVA D et al.: Tsc3p is an80-amino acid protein associated with serine palmitoyltransferase and required for optimal activity. J. Biol. Chem. (2000) 275:7597–7603.
   PubMed Web of Science ®Google Scholar
• BEELER T, BACIKOVA D, GABLE K et al.: The Saccharo-myces cerevisiae TSCIO/YBR265w gene encoding 3-ketosphinganine reductase is identified in a screen for temperature-sensitive suppressers of the Ca2+-sensitive Acsg2 mutant. J Biol. Chem. (1998) 273:30688–30694.
   PubMed Web of Science ®Google Scholar
• GRILLEY MM, STOCK SD, DICKSON RC, LESTER RL,TAKEMOTO JY: Syringomycin gene SYR2 is essential for sphingolipid 4-hydroxylation in Saccharomyces cerevisiae. J. Biol. Chem. (1998) 273:11062–11068.
   PubMed Web of Science ®Google Scholar
• OH CS, TOKE DA, MANDALA S, MARTIN CE: EL02 andEL03, homologues of the Saccharomyces cerevisiae ELOI gene, function in fatty acid elongation and are required for sphingolipid formation. J Biol. Chem. (1997) 272:17376–17384.
   PubMed Web of Science ®Google Scholar
• HEIDLER S, RADDING J: The AURI gene in Saccharo-myces cerevisiae encodes dominant resistance to the an tifungal agent Aureobasidin A (LY295337). Antimi-crob. Agents Chemother. (1995) 39:2765–2769.
   PubMed Web of Science ®Google Scholar
• HASHIDA-OKADO T, OGAWA A, ENDO M, YASUMOTO R,TAKESAKO K, KATO I: AURI, a novel gene conferring aureobasidin resistance on Saccharomyces cerevisiae: a study of defective morphologies in Aur1p-depleted cells. Mol. Gen. Genet. (1996) 251:236–244.
   PubMedGoogle Scholar
• ZHONG W, MURPHY DJ, GEORGOPAPADAKOU NH: Inhibition of yeast inositol phosphorylceramide synthase by aureobasidin A measured by a fluorometric assay. FEBS Lett. (1999) 463:241–244.
   PubMed Web of Science ®Google Scholar
• BEELER TJ, FU D, RIVERA J et al: SURI (CSGI/BCL21), agene necessary for growth of Saccharomyces cerevisiaein the presence of high Ca2+ concentrations at 37°C, is required for mannosylation of inositolphos-phorylceramide. Mol. Gen. Genet. (1997) 255:570–579.
   PubMedGoogle Scholar
• DICKSON RC, NAGIEC EE, WELLS GB, NAGIEC MM, LESTER RL: Synthesis of mannose(inositol-P) 2-ceramide, the major sphingolipid in Saccharomyces cerevisiae, requires the IPTI (YDR072c) gene. J. Biol. Chem. (1997) 272:29620–29625.
   PubMed Web of Science ®Google Scholar
• LEBER A, FISCHER P, SCHNEITER R, KOHLWEIN SD,DAUM G: The yeast mic2 mutant is defective in the formation of mannosyl-diinositolphosphoryl ceramide. FEBS Lett. (1997) 411:211–214.
   PubMed Web of Science ®Google Scholar
• MERRILL AH, WANG E, GILCHRIST DG, RILEY RT:Fumonisins and other inhibitors of de novo sphingolipid biosynthesis. Adv. Lipid Res. (1993) 26:215–234.
   PubMedGoogle Scholar
• ZWEERINK MM, EDISON AM, WELLS GB, PINTO W, LESTER RL: Characterization of a novel, potent and specific inhibitor of serine palmitoyltransferase. Biol. Chem. (1992) 267:25032–25038.
   Web of Science ®Google Scholar
• HORN WS, SMITH JL, BILLS GF et al.: Sphingofungins Eand F: novel serine palmitoyltransferase inhibitors from Paecilomyces variotii. J. Antibiot. (1992) 45:1692–1696.
   PubMed Web of Science ®Google Scholar
• MANDALA SM, FROMMER BR, THORNTON RA et al.: Inhibition of serine palmitoyltransferase activity by lip o x amycin. j Antibiot (1994) 47:376–379.
   PubMed Web of Science ®Google Scholar
• MIYAKE Y, KOZUTSUMI Y, NAKAMURA S, FUJITA T, KAWASAKI T: Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppres-sant, ISP-1/myriocin. Biochem. Biophys. Res. Commun. (1995) 211:396–403.
   PubMed Web of Science ®Google Scholar
• MANDALA S, THORNTON R, FROMMER B, DREIKORN S, KURTZ M: Viridiofungins, novel inhibitors of sphingolipid synthesis. J Antibiot. (1997) 50:339–343.
   PubMed Web of Science ®Google Scholar
• WANG E, NORRED WP, BACON CW, RILEY RT, MERRILL AH: Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. (1991) 266:14486–14890.
   PubMed Web of Science ®Google Scholar
• MERRILL AH: Fumonisins and other inhibitors of denovo sphingolipid biosynthesis. In: Advances in Lipid Research: Sphingolipids and their Metabolites. Bell RM, Hannum YA, Merrill AH (Eds.), Academic Press, San Diego, USA (1993) 26:215–234.
   Google Scholar
• MANDALA S, THORNTON R, FROMMER B et al.: The discovery of australifungin, a novel inhibitor of sp h in gan in e N-acyl tr an s f er as e from Sporormiella australis. Producing organism, fermentation, isolation and biological activity. J. Antibiol (1995) 48:349–356.
   Google Scholar
• IKAI K, TAKESAKO K, SHIOMI K et al: Structure of aureobasidin A. J Antibiol (1991) 44:925–933.
   PubMed Web of Science ®Google Scholar
• TAKESAKO K, IKAI K, HARUNA F et al.: Aureobasidins, new antifungal antibiotics: taxonomy, fermentation, isolation and properties. J Antibiol (1991) 44:919–924.
   PubMed Web of Science ®Google Scholar
• TAKESAKO K, KURODA H, INOUE T et al.: Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic. J Antibiol (1993) 46:1414–1420.
   PubMed Web of Science ®Google Scholar
• OGAWA A, HASHIDA-OKADO T, ENDO M et al: Role of ABC transporters in aureobasidin A resistance. Antimi-crob. Agents Chemother. (1998) 42:755–761.
   PubMed Web of Science ®Google Scholar
• AWAZU N, IKAI K, YAMAMOTO J et al: Structures and antifungal activities of new aureobasidins. j Antibiol (1995) 48:525–527.
   PubMed Web of Science ®Google Scholar
• MANDALA S, THORNTON R, ROSENBACH M et al: Khafrefungin, a novel inhibitor of sphingolipid synthesis. J. Biol. Chem. (1997) 272:32709–32714.
   PubMed Web of Science ®Google Scholar
• ACHENBACH H, MUHLENFELD A, FAUTH U, ZAHNER H: The galbonolides. Novel powerful antifungal macrolides from Streptomyces galbus spp. Eurythermus. Ann. NY Acad. Sci. (1988) 544:128–140.
   Google Scholar
• MANDALA SM, THORNTON RA, MILLIGAN J et al.: Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase. J. Biol. Chem. (1998) 273:14942–14949.
   PubMed Web of Science ®Google Scholar
• HARRIS GH, SHAFFIE A, CABELLO MA et al.: Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs. J. Antibiot. (1998) 51:837–844.
   PubMed Web of Science ®Google Scholar
• GORDEE R, FARMER J, ZECKNER D: LY295337 a novel cyclic depsipeptide antifungal antibiotic. I. In vitro antifungal activity. In: Abstracts of the 32ad Intersci. Conf Antimicrob. Agents Chemother. American Society for Microbiology, Washington DC, USA (1992) 496:193 (Abstract).
   Google Scholar
• ZECKNER D, BUTLER T, BOYLAN C et al: LY295337 anovel cyclic depsipeptide antifungal antibiotic. II. In vivo antifungal activity. In: Abstracts of the 32a1 Intersci. Conf Antimicrob. Agents Chemother. American Society for Microbiology, Washington DC, USA (1992) 497:193 (Abstract).
   Google Scholar
• BUTLER T, ZECKNER D, BOYLAN C et al: LY295337 a novel cyclic depsipeptide antifungal antibiotic. III. Resistance development studies. In: Abstracts of the 32nd Intersci. Conf Antimicrob. Agents Chemother. American Society for Microbiology, Washington DC, USA (1992) 498:194 (Abstract).
   Google Scholar
• RANE DF, COOPER AB, DESAI JA et al.: Anovel antifungal cyclodepsip ep tide: synthesis and structure-activity relationships of new cyclodepsipeptides. In: Abstracts of the 36th Intersci. Conf Antimicrob. Agents Chemother. American Society for Microbiology, Washington DC, USA (1996) F-196:134 (Abstract).
   Google Scholar
• COOPER AB, JAO E, RANE DF et al: Total synthesis of the antifungal cyclic depsipeptides 5CH53174 and 54256. In: Abstracts of the 214th American Chemical Society National Meeting (Div. Med. Chem.). Div. Med. Chem., Amer. Chem. Soc., Washington DC, USA (1997):159.
   Google Scholar